Literature DB >> 21508325

Boosting understanding of pertussis outbreaks.

Bryan Grenfell1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21508325      PMCID： PMC3088611          DOI： 10.1073/pnas.1103408108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Opposite patterns of synchrony in sympatric disease metapopulations.

Authors:  P Rohani; D J Earn; B T Grenfell
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster.

Authors:  G P Garnett; B T Grenfell
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

3.  Pathogen adaptation under imperfect vaccination: implications for pertussis.

Authors:  Michiel van Boven; Frits R Mooi; Joop F P Schellekens; Hester E de Melker; Mirjam Kretzschmar
Journal:  Proc Biol Sci       Date:  2005-08-07       Impact factor: 5.349

4.  Vaccination and the dynamics of immune evasion.

Authors:  Olivier Restif; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

5.  An age-structured model for pertussis transmission.

Authors:  H W Hethcote
Journal:  Math Biosci       Date:  1997-10-15       Impact factor: 2.144

Review 6.  Reflections on the efficacy of pertussis vaccines.

Authors:  P E Fine; J A Clarkson
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

7.  Distribution of immunity to pertussis in the population of England and Wales.

Authors:  P E Fine; J A Clarkson
Journal:  J Hyg (Lond)       Date:  1984-02

8.  New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.

Authors:  Kevin D Forsyth; Magda Campins-Marti; Jaime Caro; James D Cherry; David Greenberg; Nicole Guiso; Ulrich Heininger; Joop Schellekens; Tina Tan; Carl-Heinz Wirsing von König; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2004-11-18       Impact factor: 9.079

9.  Estimating the duration of pertussis immunity using epidemiological signatures.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

10.  Social contacts and mixing patterns relevant to the spread of infectious diseases.

Authors:  Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Journal:  PLoS Med       Date:  2008-03-25       Impact factor: 11.069
View more
  6 in total

1.  Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I.

Authors:  Dominik Schuler; Carolin Lübker; Gerald H Lushington; Wei-Jen Tang; Yuequan Shen; Mark Richter; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2012-01-13       Impact factor: 5.858

Review 2.  Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.

Authors:  Dominik Alexander Bloes; Dorothee Kretschmer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

3.  Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.

Authors:  Jennie S Lavine; Ottar N Bjørnstad; Birgitte Freiesleben de Blasio; Jann Storsaeter
Journal:  Vaccine       Date:  2011-11-26       Impact factor: 3.641

4.  Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderly.

Authors:  Lisa J McGarry; Girishanthy Krishnarajah; Gregory Hill; Michelle Skornicki; Narin Pruttivarasin; Cristina Masseria; Bhakti Arondekar; Stephen I Pelton; Milton C Weinstein
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

5.  Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.

Authors:  Lisa J McGarry; Girishanthy Krishnarajah; Gregory Hill; Cristina Masseria; Michelle Skornicki; Narin Pruttivarasin; Bhakti Arondekar; Julie Roiz; Stephen I Pelton; Milton C Weinstein
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

6.  Calpain-Mediated Processing of Adenylate Cyclase Toxin Generates a Cytosolic Soluble Catalytically Active N-Terminal Domain.

Authors:  Kepa B Uribe; Aitor Etxebarria; César Martín; Helena Ostolaza
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.